Lee Jivianne T, Chiu Alexander G
Orange County Sinus Institute, Southern California Permanente Medical Group, Irvine, California, USA.
Am J Rhinol Allergy. 2014 Jan-Feb;28(1):29-38. doi: 10.2500/ajra.2014.28.3988.
Sinonasal anti-infective irrigations have emerged as a promising therapeutic modality in the comprehensive management of chronic rhinosinusitis (CRS), particularly in the context of recalcitrant disease. The purpose of this article was to delineate the current spectrum of topical anti-infective therapies available and evaluate their role in the treatment of CRS.
A systematic literature review was performed on all studies investigating the use of topical antimicrobial solutions in the medical therapy of CRS. Anti-infective irrigations were stratified into topical antibacterial, antifungal, and additive preparations according to their composition and respective microbicidal properties.
The use of topical antibiotic irrigations has been supported by low-level studies in the treatment of refractory CRS, with optimal results achieved in patients who have undergone prior functional endoscopic sinus surgery and received culture-directed therapy. Multiple evidence-based reviews have not established any clinical benefit with the administration of topical antifungals, and their use is not currently recommended in the management of routine CRS. Topical additives including surfactants may be beneficial as adjunctive treatment for recalcitrant CRS, but additional research is needed to investigate their efficacy in comparison with other agents and establish safety profiles.
Topical anti-infective solutions are not recommended as first-line therapy for routine CRS but may be considered as a potential option for patients with refractory CRS who have failed traditional medical and surgical intervention. Additional research is necessary to determine which patient populations would derive the most benefit from each respective irrigation regimen and identify potential toxicities associated with prolonged use.
鼻窦抗感染冲洗已成为慢性鼻-鼻窦炎(CRS)综合治疗中一种有前景的治疗方式,尤其是在治疗顽固性疾病方面。本文旨在阐述目前可用的局部抗感染治疗方法,并评估它们在CRS治疗中的作用。
对所有研究局部抗菌溶液在CRS药物治疗中应用的研究进行系统的文献综述。根据抗感染冲洗液的成分和各自的杀菌特性,将其分为局部抗菌、抗真菌和添加剂制剂。
低水平研究支持局部抗生素冲洗用于治疗难治性CRS,在先前接受过功能性鼻内镜鼻窦手术并接受针对性培养治疗的患者中取得了最佳效果。多项基于证据的综述未证实局部使用抗真菌药物有任何临床益处,目前不建议在常规CRS管理中使用。包括表面活性剂在内的局部添加剂可能作为顽固性CRS辅助治疗有益,但需要更多研究来调查其与其他药物相比的疗效并确定安全性。
局部抗感染溶液不推荐作为常规CRS的一线治疗,但对于传统药物和手术干预失败的难治性CRS患者可考虑作为一种潜在选择。需要更多研究来确定哪些患者群体能从每种冲洗方案中获益最大,并确定与长期使用相关的潜在毒性。